BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those ...

Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the ...

Lennar (LEN – Research Report) received a Hold rating and price target from BTIG analyst Carl Reichardt yesterday. The company’s shares ...

From "Apple Stock Hasn’t Had a Streak Like This Since 2010. What It Means as Value Nears $4 Trillion." posted Thursday by ...

Ready Capital Corp (RC) stock saw a decline, ending the day at $7.35 which represents a decrease of $-0.04 or -0.54% from the prior close of $7.39. The stock opened at $7.31 and touched a low of $7.26 ...

BTIG raised the firm’s price target on Darden (DRI) to $205 from $195 and keeps a Buy rating on the shares after its Q2 ...

Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.93 which represents a slight increase of $0.07 or 3.76% from the prior close of $1.86. The stock opened at $1.86 and ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at BTIG, in a note. “Brinker International (EAT) is not in the S&P 500 ...

BTIG’s Jonathan Krinsky is bullish on AppLovin Corporation (NASDAQ:APP), Flutter Entertainment (NYSE:FLUT), DraftKings (NASDAQ:DKNG), and Roblox Corporation (NYSE:RBLX), as he tagged Buy ratings ...

BTIG initiated coverage of Cartesian Therapeutics (RNAC) with a Buy rating and $42 price target Cartesian is pioneering the field of mRNA-based CART cell therapies for autoimmune disorders, the ...

BTIG Research lowered shares of Innovative Industrial Properties (NYSE:IIPR – Free Report) from a buy rating to a neutral ...